Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential Benefits and Risks Associated with the Use of Statins
Nisha Khatiwada, Zhongkui Hong
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 214-214
Open Access | Times Cited: 22

Showing 22 citing articles:

A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies
Vasudeva Reddy Netala, Sireesh Kumar Teertam, Huizhen Li, et al.
Cells (2024) Vol. 13, Iss. 17, pp. 1471-1471
Open Access | Times Cited: 11
The Association Between Statin Drugs and Rhabdomyolysis: An Analysis of FDA Adverse Event Reporting System (FAERS) Data and Transcriptomic Profiles
Robert Morris, Kun Bu, Weiru Han, et al.
Genes (2025) Vol. 16, Iss. 3, pp. 248-248
Open Access | Times Cited: 1
Regulatory effects of statins on Akt signaling for prevention of cancers
Fatemeh Hosseini, Abdolreza Ahmadi, Prashant Kesharwani, et al.
Cellular Signalling (2024) Vol. 120, pp. 111213-111213
Closed Access | Times Cited: 5
Role of Statins in Reducing Cardiovascular Mortality: A Systematic Review of Long-Term Outcomes
Bhavna Seth, David Okello, Syed Saad Ullah, et al.
Cureus (2025)
Open Access
Association between hyperuricemia and all-cause mortality in people taken Statins: a retrospective cohort study
Bin Zhu, Zijun He, Mingfen Wu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
The Role of Statins in Managing Chronic Kidney Disease: A Comprehensive Review
Saket Toshniwal, P Avinash, Anand C. Loya, et al.
International journal of Nutrition Pharmacology Neurological Diseases (2025) Vol. 15, Iss. 1, pp. 10-17
Closed Access
Insulin resistance and cancer: molecular links and clinical perspectives
Alfredo Caturano, Enes Erul, Roberto Nilo, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
Effect of Dietary Supplementation of Fructobacillus fructosus MCC 3996 on Body Weight, Serum Lipid and Liver Histopathology of High‑Fat Diet-Fed Swiss Albino Mice
Mahesh P. Patil, Jayshri Bhuktar, Jayesh J. Ahire, et al.
The Microbe (2025), pp. 100295-100295
Open Access
The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies
Dimitris Kounatidis, Nikolaοs Tentolouris, Natalia G. Vallianou, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 388-388
Open Access | Times Cited: 3
Off‐target effects of statins: molecular mechanisms, side effects and the emerging role of kinases
Francisco Alejandro Lagunas‐Rangel, E. Liepinsh, Robert Fredriksson, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 20, pp. 3799-3818
Open Access | Times Cited: 3
Role of Phytochemicals in Cardiovascular Disease Management: Insights into Mechanisms, Efficacy, and Clinical Application
Esther Ugo Alum
Phytomedicine Plus (2024), pp. 100695-100695
Open Access | Times Cited: 2
The effect of supplementation of vitamin D on hyperlipidemia and bone mass in the pediatric with obesity
Feifan Wang, Lingshan Bei, Xiaoyan Zhang, et al.
Critical Reviews in Immunology (2024) Vol. 45, Iss. 1, pp. 31-39
Closed Access | Times Cited: 1
Statin Hyperlipidaemia: What Else?
Susmita Sinha, Kona Chowdhury, Rahnuma Ahmed, et al.
Advances in Human Biology (2024) Vol. 14, Iss. 4, pp. 257-260
Open Access | Times Cited: 1
In Silico Approach for Identification of Potential Tetracyclic Triterpenoids from Mushroom as HMG-CoA Reductase Inhibitor
Rishav Mazumder, Deijy Choudhury, Alekhya Sarkar, et al.
Aspects of Molecular Medicine (2024) Vol. 4, pp. 100053-100053
Open Access | Times Cited: 1
New Advances in Cardiovascular Drugs: A Celebration of the 90th Birthday of Professor Akira Endo
Alfredo Caturano
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2716-2716
Open Access | Times Cited: 1
Advancements in the Treatment of Atherosclerosis: From Conventional Therapies to Cutting-Edge Innovations
Yan Liu, Kuan Lu, Ruru Zhang, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3804-3826
Closed Access | Times Cited: 1
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease
Alfredo Caturano, Raffaele Galiero, Maria Rocco, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1393-1393
Open Access
Risk of Sarcopenia Following Long‐Term Statin Use in Community‐Dwelling Middle‐Aged and Older Adults in Japan
Shih‐Tsung Huang, Rei Otsuka, Yukiko Nishita, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 16, Iss. 1
Open Access
Association between statin use and 30-day mortality among patients with sepsis-associated encephalopathy: a retrospective cohort study
Junwei Chen, Jinou Chen, Lihong Li
Frontiers in Neurology (2024) Vol. 15
Open Access
A comparison of dry bean and pea consumption on serum cholesterol: A randomized controlled trial in adults with mild hypercholesterolemia
Rhonda C. Bell, Peter Zahradka, Michel Aliani, et al.
Journal of Nutrition (2024)
Closed Access
Repurposing simvastatin for treatment of Klebsiella pneumoniae infections: in vitro and in vivo study
Ehssan Moglad, Engy Elekhnawy, Nuor Alanazi, et al.
Biofouling (2024), pp. 1-15
Closed Access
Leukocytosis as a Risk Factor for Coronary Artery Disease: Pathophysiology and Epidemiology
Toka Amin, Muhammad Haseeb ul Rasool, Bike Ilyada Ozkan, et al.
Cardiology in Review (2024)
Closed Access
Page 1

Scroll to top